Literature DB >> 26299273

Marijuana Use in Epilepsy: The Myth and the Reality.

Kamil Detyniecki1, Lawrence Hirsch.   

Abstract

Marijuana has been utilized as a medicinal plant to treat a variety of conditions for nearly five millennia. Over the past few years, there has been an unprecedented interest in using cannabis extracts to treat epilepsy, spurred on by a few refractory pediatric cases featured in the media that had an almost miraculous response to cannabidiol-enriched marijuana extracts. This review attempts to answer the most important questions a clinician may have regarding the use of marijuana in epilepsy. First, we review the preclinical and human evidences for the anticonvulsant properties of the different cannabinoids, mainly tetrahydrocannabinol (THC) and cannabidiol (CBD). Then, we explore the safety data from animal and human studies. Lastly, we attempt to reconcile the controversy regarding physicians' and patients' opinions about whether the available evidence is sufficient to recommend the use of marijuana to treat epilepsy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26299273     DOI: 10.1007/s11910-015-0586-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  35 in total

1.  Dose-related neurocognitive effects of marijuana use.

Authors:  K I Bolla; K Brown; D Eldreth; K Tate; J L Cadet
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

2.  The case for medical marijuana in epilepsy.

Authors:  Edward Maa; Paige Figi
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

3.  Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report.

Authors:  Dimah Saade; Charuta Joshi
Journal:  Pediatr Neurol       Date:  2015-02-19       Impact factor: 3.372

4.  Intractable epilepsy: A survey of patients and caregivers.

Authors:  James W Wheless
Journal:  Epilepsy Behav       Date:  2006-05-03       Impact factor: 2.937

5.  Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia's survey.

Authors:  Gary W Mathern; Laurie Beninsig; Astrid Nehlig
Journal:  Epilepsia       Date:  2014-11-20       Impact factor: 5.864

6.  Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice.

Authors:  P Consroe; M A Benedito; J R Leite; E A Carlini; R Mechoulam
Journal:  Eur J Pharmacol       Date:  1982-09-24       Impact factor: 4.432

7.  Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity.

Authors:  Melisa J Wallace; Billy R Martin; Robert J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2002-10-11       Impact factor: 4.432

8.  Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center.

Authors:  D W Gross; J Hamm; N L Ashworth; D Quigley
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

9.  Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.

Authors:  P Consroe; A Wolkin
Journal:  J Pharmacol Exp Ther       Date:  1977-04       Impact factor: 4.030

10.  Placebo by proxy.

Authors:  David J Grelotti; Ted J Kaptchuk
Journal:  BMJ       Date:  2011-08-11
View more
  5 in total

Review 1.  Building smart cannabis policy from the science up.

Authors:  Susan R B Weiss; Katia D Howlett; Ruben D Baler
Journal:  Int J Drug Policy       Date:  2017-02-08

Review 2.  Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview.

Authors:  Anna Capasso
Journal:  Open Neurol J       Date:  2017-12-18

3.  Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety.

Authors:  Orit Stolar; Ariela Hazan; Roni Enten Vissoker; Ibrahim Abu Kishk; Dana Barchel; Mirit Lezinger; Adi Dagan; Nir Treves; David Meiri; Matitiahu Berkovitch; Elkana Kohn; Eli Heyman
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

Review 4.  Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

Authors:  Emilio Perucca
Journal:  J Epilepsy Res       Date:  2017-12-31

5.  Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities.

Authors:  Dana Barchel; Orit Stolar; Tal De-Haan; Tomer Ziv-Baran; Naama Saban; Danny Or Fuchs; Gideon Koren; Matitiahu Berkovitch
Journal:  Front Pharmacol       Date:  2019-01-09       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.